Challenge
Most pharmaceutical companies don’t sell their medicine directly to patients, they sell them to Health Care Professionals like hospitals and pharmacies. Those Health Care Professionals act as intermediaries in the medical sales process. This is the reason pharmaceutical companies, who are the producer of the drugs, are often losing track of its in-market sales. They lack answers to key questions like “Are we losing or gaining patients?” or “How is our newest drug performing?”.
This was also the case for one of our clients. As a manner to cope with this blind spot, our client spends millions of dollars per year on purchasing commercial data from an external data provider. This way, our client is able to get insight into their in-market sales by analysing this third-party data. To keep track of KPIs, our client has built several dashboards in a Business Intelligence environment. However, the business stakeholders who consumed these dashboards had little trust in them. Mostly because there was no visibility on the quality of the underlying data.
One of the datasets contained aggregated sales numbers such as the total sales per speciality and per month. The aggregation of raw sales data was done by the third party. This results in a lack of transparency on how the data has been transformed.
To increase the trust in the third-party data and the KPI dashboards, the IT department at our client has to perform data quality checks manually. This appeared to be a rigid process that hindered the proactive identification of data quality issues.
Approach
Our approach was to implement a robust data quality framework that would empower business stakeholders to detect data quality issues in the third-party data themselves, in a proactive way. With Collibra Data Quality & Observability as the tool of choice, the focus was on implementing an easy-to-use and intuitive platform. Our aim was to enable new users to seamlessly participate in the data quality process, fostering a culture of data cleanliness and accuracy.
Examples of technical and functional support provided to our client for this use case were:
Impact
The implementation of the proactive data quality process led to significant improvements for our client: data quality issues in the third-party data were easily detected, raised and resolved.
This successful use case has sparked interest throughout the client's organization, as it clearly demonstrates how a proactive approach on data quality can result in tangible business value. Datashift continues to drive improvements in data quality, helping our client achieve more trust in both third-party data and their own data, driving growth in the pharmaceutical industry.